SCHEMBL4625455

SCHEMBL4625455

COC(OC)C(O)c1cc(Cl)ccc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.47
KMT2A Q03164 8/20 0.47
HPGD P15428 7/20 0.47
ALDH1A1 P00352 6/20 0.47
TDP1 Q9NUW8 4/20 0.47
GAA P10253 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPT P10636 4/20 0.46
HTT P42858 4/20 0.46
MAPK1 P28482 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
TSHR P16473 3/20 0.41
HSD17B10 Q99714 4/20 0.41
ALOX15 P16050 4/20 0.38
ALOX12 P18054 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
PPARG P37231 1/20 0.38
NCOA2 Q15596 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4624079 0.80 TRPA1 (0.43) MEN1KMT2AHPGDALDH1A1TDP1
SCHEMBL4627227 0.77 ALDH1A1 (0.50) MEN1KMT2AHPGDALDH1A1TDP1
SCHEMBL2982934 0.75 MEN1 (0.58) MEN1KMT2AHPGDALDH1A1TDP1
SCHEMBL8445954 0.74 HSD17B10 (0.52) MEN1KMT2AHPGDALDH1A1TDP1
SCHEMBL4624282 0.73 GABRA1 (0.50) HPGDALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL19954062 0.72 MEN1 (0.50) MEN1KMT2AHPGDALDH1A1TDP1
SCHEMBL51491 0.72 MEN1 (0.59) MEN1KMT2AHPGDALDH1A1TDP1
SCHEMBL815863 0.72 MEN1 (0.59) MEN1KMT2AHPGDALDH1A1TDP1
SCHEMBL27499901 0.71 HTR1A (0.45) HPGDHTTMAPK1NPSR1ALOX15
SCHEMBL26668395 0.69 LMNA (0.59) MEN1KMT2AHPGDALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1125908-B1 New phenolic compounds derived from dialkoxyethanals, their preparation process and their application CLARIANT SPECIALTY FINE CHEM (FR) 2008-06-04 EP claimed
EP-1125908-B1 New phenolic compounds derived from dialkoxyethanals, their preparation process and their application CLARIANT SPECIALTY FINE CHEM (FR) 2008-06-04 EP disclosed
EP-1125908-B1 New phenolic compounds derived from dialkoxyethanals, their preparation process and their application CLARIANT SPECIALTY FINE CHEM (FR) 2008-06-04 EP disclosed
US-6774267-B2 REACTING A PHENOL COMPOUND WITH AN ALDEHYDE CONTAINING DIALKOXYMETHYL OR 1,3-DIOXOLAN-2-YL GROUP IN PRESENCE OF A BASE CLARIANT FRANCE (FR) 2004-08-10 US disclosed
US-20010016664-A1 New phenolic compounds derived from dialkoxyethanals, their preparation process and their application CLARIANT (FRANCE) S.A. 2001-08-23 US disclosed
EP-1125908-A1 New phenolic compounds derived from dialkoxyethanals, their preparation process and their application Clariant (France) S.A. (FR) 2001-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010016664-A1 New phenolic compounds derived from dialkoxyethanals, their preparation process and their application CYC1, CCNY, MT-CO1 MEN1 2698/4885KMT2A 1895/4885HPGD 1745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.